Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-053513
Filing Date
2022-04-29
Accepted
2022-04-29 16:01:51
Documents
5
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2213833d1_def14a.htm DEF 14A 413633
2 GRAPHIC tm2213833d1_def14aimg01.jpg GRAPHIC 13651
3 GRAPHIC tm2213833d1_def14aimg02.jpg GRAPHIC 4720
4 GRAPHIC tm2213833d1_def14aimg03.jpg GRAPHIC 120253
5 GRAPHIC tm2213833d1_def14aimg04.jpg GRAPHIC 135587
  Complete submission text file 0001104659-22-053513.txt   792914
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39580 | Film No.: 22875053
SIC: 2834 Pharmaceutical Preparations